Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-01-07

Clinical Trial Update: Denosumab Adherence Preference Satisfaction Study [Phase 3]

View source ↗

Summary

Phase 3 trial assessing adherence, preference, and satisfaction with denosumab in osteoporosis; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Denosumab (denosumab)

Snippet

Sponsor: Amgen | Conditions: Osteoporosis | Phase 3 | Status: COMPLETED | Results posted: 2014-01-07